| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
ORIX Corporation (ADR)
| NYSE
|
IX
|
79.60
|
|
+0.01
(0.01%)
| 17.12B
|
|
|
ORIX CORPORATION is a financial company. The Corporate Financial Service segment
is engaged in financing, leasing and financial instrument selling.
| |
| |
|
|
First Trust NASDAQ-100- Technology Ix Fd
| NASDAQ
|
QTEC
|
29.53
|
|
+0.05
(0.17%)
| 117.92M
|
|
|
First Trust NASDAQ-100-Technology Index Fund (the Fund), formerly First Trust
NASDAQ-100-Technology Sector Index Fund, seeks investment results that ...
| |
| |
|
|
Deutsche Bank Cap Fdg Tr IX Guaranteed Trust Preferred Securities
| NYSE
|
DTT
|
25.43
|
|
0.00
(0.00%)
| 1.17B
|
|
|
|
|
|
SunTrust Banks, Inc. Suntrust Capital IX 7.875% Trust Preferred Securities
| NYSE
|
STI-Z
|
0.0000
|
|
|
|
|
|
|
|
|
Wachovia Cap Tr IX 6.375 Guaranteed Trust Preferred Securities 06/15/2047
| NYSE
|
WB-C.CL
|
25.00
|
|
| 750.00M
|
|
|
|
|
|
FleetBoston Financial Corporation Fleet Capital Trust IX
| NYSE
|
FBF-N.CL
|
25.34
|
|
| 177.45M
|
|
|
|
|
|
IX Energy Holdings Inc
| OTCMKTS
|
IXEH
|
0.0016
|
|
0.0000
(0.00%)
| 112,709.00
|
|
|
IX Energy Holdings, Inc., formerly Yoo Inc. is engaged in development and
financing of solar power and other renewable energy solutions systems.
| |
| |
|
|
Inform Exploration Corp
| CVE
|
IX
|
0.100
|
|
0.000
(0.00%)
| 829,000.00
|
|
|
Inform Exploration Corp. (Inform) is engaged in the acquisition, exploration and
, if warranted, development of natural resource properties of merit.
| |
| |
|
|
ATEL CAP EQUIP FD IX
| OTCMKTS
|
ZZHJC
|
2.00
|
|
0.00
(0.00%)
|
|
|
|
|
|
|
IX Europe Plc (Inactive)
| Private
|
|
|
|
|
|
|
|
|
|
|
Baxter International Inc.
| NYSE
|
BAX
|
73.04
|
|
+0.10
(0.14%)
| 39.58B
|
|
|
Baxter International Inc. (Baxter) is a global, diversified healthcare company.
Baxter, through its subsidiaries, develops, manufactures and markets ...
| |
| |
|
|
UBS IS - Gold ETF (USD) IX
| SWX
|
AUUSX-EUR
|
|
|
|
|
|
|
|
|
|
PROLOR Biotech Inc
| NYSEMKT
|
PBTH
|
6.44
|
|
+0.03
(0.47%)
| 408.49M
|
|
|
As of December 31, 2011, the Company's product development program is focused on
extending the life span of Human Growth Hormone (hGH), Factor IX, ...
| |
| |
|
|
BAXTER INTL DL 1
| FRA
|
BTL
|
56.49
|
|
-0.62
(-1.09%)
|
|
|
|
|
|
|
PROLOR BIOTECH INC.
| FRA
|
M3D
|
4.91
|
|
-0.08
(-1.62%)
|
|
|
|
|
|
|
PROLOR BIOTECH
| TLV
|
PBTH
|
2,370.00
|
|
+4.00
(0.17%)
|
|
|
|
|
|
|
I.X.(IE)O.IB.USD GOVT 3-7
| INDEXDB
|
AL8Z
|
118.22
|
|
+0.12
(0.10%)
|
|
|
|
|
|
|
BAXTER INTL
| SWX
|
BAX
|
|
|
|
|
|
|
|
|
|
BAXTER INTL DL 1
| ETR
|
BTL
|
57.34
|
|
0.00
(0.00%)
|
|
|
|
|
|
|
Pfizer Inc.
| NYSE
|
PFE
|
28.78
|
|
+0.08
(0.28%)
| 206.90B
|
|
|
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The
Company manages its operations through five segments: Primary Care; ...
| |
| |
|
|
Show all 48 companies »
|
|
